Asp Isotopes Inc. (ASPI) Stock Price & Analysis
Asp Isotopes Inc. (ASPI) fell 6.30% to USD 6.4 as of June 10, 2026 at 08:36 UTC, according to Nexqual real-time market data.
ASPI last closed at USD 6.83; the session ranged USD 6.06–7.1 on volume of 6,424,004 shares. Market capitalization is $805.78M, with a 52-week range of USD 3.92–14.49 (NCM). Source: Nexqual, June 10, 2026 at 08:36 UTC.
Key Statistics (as of June 10, 2026 at 08:36 UTC)
| Price | USD 6.4 |
|---|---|
| Change | ▼ 6.30% (down) |
| Previous Close | USD 6.83 |
| Open | USD 6.8 |
| Day Range | USD 6.06 – 7.1 |
| 52-Week Range | USD 3.92 – 14.49 |
| Volume | 6,424,004 shares |
| Market Cap | $805.78M |
| Exchange | NCM |
Technical Analysis (ASPI)
Nexqual's technical model rates ASPI "STRONG BUY" based on 5 bullish and 0 bearish signals across 123 daily candles, as of June 10, 2026 at 08:36 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 53.42 (neutral) |
| vs SMA50 | Above (USD 5.59) |
| MACD | 0.55 (positive) |
Analyst Ratings (ASPI)
Wall Street analysts rate ASPI "Strong Buy" based on 3 analysts, with a mean price target of USD 13 (range USD 11–15), per Nexqual as of June 10, 2026 at 08:36 UTC.
| Consensus Rating | Strong Buy |
|---|---|
| Analyst Count | 3 |
| Mean Target | USD 13 |
| High Target | USD 15 |
| Low Target | USD 11 |
| Buy / Hold / Sell | 3 / 0 / 0 |
Earnings (ASPI)
| Next Earnings Date | 2026-08-14 |
|---|---|
| EPS Estimate | USD -0.31 |
| Revenue Estimate | $1.50M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD -0.05 vs est -0.28 ▲ beat |
| 2025-12-31 | USD -0.41 vs est -0.14 ▼ miss |
| 2025-09-30 | USD -0.15 vs est -0.1 ▼ miss |
| 2025-06-30 | USD -1.03 vs est -0.11 ▼ miss |
Source: Nexqual, June 10, 2026 at 08:36 UTC.
Financials & Fundamentals (ASPI)
| Total Revenue | $26.93M |
|---|---|
| Revenue Growth (YoY) | +279.30% |
| Gross Margin | +17.62% |
| Operating Margin | -595.41% |
| Profit Margin | +0.00% |
| ROE | -103.32% |
| Debt / Equity | 87.57 |
| Current Ratio | 4.39 |
| Total Cash | $290.52M |
| Total Debt | $261.84M |
| Free Cash Flow | $-39.83M |
Source: Nexqual, June 10, 2026 at 08:36 UTC.
Financial Health Score (ASPI)
Nexqual rates Asp Isotopes Inc.'s overall financial health "Weak" across five dimensions, as of June 10, 2026 at 08:36 UTC.
| Growth | Strong — Revenue +475% YoY (annual) |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — $291M cash vs $262M debt, net cash position |
| Cash Flow | Weak — FCF negative: -$40M, burning cash |
| Efficiency | Critical — ROE -103%, ROA -13.7% |
Ownership (ASPI)
| Insider Ownership | +13.19% |
|---|---|
| Institutional Ownership | +56.94% |
| Shares Outstanding | 125.90M |
| Float | 95.84M |
| Short % of Float | +20.00% |
Source: Nexqual, June 10, 2026 at 08:36 UTC.
Leadership (ASPI)
Asp Isotopes Inc. is led by Paul Elliot Mann C.F.A. (age 48), Executive Chairman & CEO, per Nexqual as of June 10, 2026 at 08:36 UTC.
| Executive Chairman & CEO | Paul Elliot Mann C.F.A. (age 48) |
|---|---|
| Chief Financial Officer | Heather Kiessling (age 60) |
| Chief Operating Officer | Robert Ainscow (age 48) |
| Co-Chief Operating Officer | Nicholas Michael Mitchell (age 45) |
| Chief Technology Officer | Hendrik Strydom B. Sc, M. Sc (age 64) |
Major Backers & Investors (ASPI)
Notable institutional backers of Asp Isotopes Inc. include Encompass Capital Advisors, LLC, Rovida Investment Management Ltd, Exchange Traded Concepts LLC, according to Nexqual as of June 10, 2026 at 08:36 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Encompass Capital Advisors, LLC | 5.49% |
| Rovida Investment Management Ltd | 3.26% |
| Exchange Traded Concepts LLC | 2.89% |
| UBS Group AG | 2.26% |
| Alyeska Investment Group, L.p. | 2.14% |
| AWM Investment Company, Inc. | 1.69% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 9.45% |
| Vanguard Group | 8.31% |
| Geode Capital | 2.18% |
| State Street | 1.84% |
Source: Nexqual, June 10, 2026 at 08:36 UTC.
From Asp Isotopes Inc.'s Latest SEC 10-K Filing (filed 2026-04-10)
Key Strengths & Strategy (as disclosed to the SEC)
- Our proprietary enrichment technologies, the Aerodynamic Separation Process ("ASP technology") and Quantum Enrichment technology ("QE technology"), are designed to enable the production of isotopes for a range of industrial and advanced technology applications.
- We plan to begin research and development for the enrichment of uranium to demonstrate our capability to produce HALEU using QE technology.
- We believe we compare favorably with many of our helium competitors due our geographic location near the Cape of Good Hope, which we believe will allow us to provide helium to parts of the world that other competitors, such as companies located in Qatar, cannot.
Partnerships
- On March 29, 2026, QLE entered into a securities exchange agreement with an investor (the "QLE Exchange Agreement").
- Agreements with TerraPower LLC On April 4, 2024, we entered into an agreement with TerraPower to develop a conceptual design, refined cost/schedule/financing, risk register, and term sheet for a HALEU facility (the "TerraPower Agreement").
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| LTBR | Lightbridge Corporation | USD 9.16 | ▼ 2.76% |
| NNE | Nano Nuclear Energy Inc. | USD 23.94 | ▲ 1.61% |
| LEU | Centrus Energy Corp. | USD 156.02 | ▼ 3.56% |
| EU | enCore Energy Corp. | USD 1.28 | ▼ 7.25% |
| EOSE | Eos Energy Enterprises, Inc. | USD 6.26 | ▼ 11.58% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 08:36 UTC. This page is informational and not investment advice.